Strong signals associated with osteomyelitis were generated for canagliflozin or any drug groups containing canagliflozin, whereas weak signals were generated for insulin–osteomyelitis pairs, and no signal was generated for other hypoglycemic drugs or drug groups excluding canagliflozin and insulin. This evidence concerns the gene INS and osteomyelitis.